Stay updated on Expanded Access to Upadacitinib Clinical Trial
Sign up to get notified when there's something new on the Expanded Access to Upadacitinib Clinical Trial page.
Latest updates to the Expanded Access to Upadacitinib Clinical Trial page
- Check3 days agoChange DetectedMinor version update from v3.3.3 to v3.3.4 detected; page content and layout remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedFooter updated to show Revision: v3.3.3, with HHS Vulnerability Disclosure and Revision: v3.3.2 removed.SummaryDifference0.1%
- Check53 days agoChange DetectedRevision history shows a new entry v3.3.2 and removal of v3.2.0. No substantive study content or eligibility details were changed.SummaryDifference0.1%
- Check60 days agoChange DetectedThe government funding/operating status notice was removed from the page. No core study information such as eligibility criteria, interventions, or contact details appears to have changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%
- Check74 days agoChange DetectedThe new screenshot shows minor visual/layout adjustments to the study page, while core study details (conditions, eligibility criteria, and contact information) remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%
- Check103 days agoChange DetectedThe page now includes an operating-status notice and a version update to v3.2.0, while removing the previous v3.1.0 reference.SummaryDifference8%
Stay in the know with updates to Expanded Access to Upadacitinib Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Expanded Access to Upadacitinib Clinical Trial page.